Diego Dal Ben

ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 23

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Expert opinion on therapeutic patents

Journal of medicinal chemistry

University of Camerino

University of Padova (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Camerino Nov 05 2015

Italy

Associate Professor :: School of Pharmacy

University of Camerino Jun 01 2011 - Nov 04 2015

Italy

Researcher :: School of Pharmacy

University of Camerino Jun 01 2005 - May 31 2011

Italy

Researcher (Temp. Position) :: School of Pharmacy

GlaxoSmithKline

Italy

Researcher

Education History

University of Padova

Italy

PHD

Publications

Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions. Molecules (Basel, Switzerland) 28 (4) (2023)
Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions. Molecules (Basel, Switzerland) 28 (4) (2023)
Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions. Molecules (Basel, Switzerland) 28 (4) (2023)
Beatrice Francucci, Simone Angeloni, Diego Dal Ben, Catia Lambertucci, Massimo Ricciutelli, Andrea Spinaci, Aleksei N Smirnov, Rosaria Volpini, Michela Buccioni, Gabriella Marucci
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A 2A Adenosine Receptor Useful in Neurodegenerative Disorders. Molecules (Basel, Switzerland) 28 (12) (2023)
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, Chang Cui, Vittoria Colotta, Diego Dal Ben, Eleonora Cescon, Beatrice Francucci, Ilenia Grieco, Catia Lambertucci, Gabriella Marucci, Davide Bassani, Matteo Pavan, Flavia Varano, Stephanie Federico, Giampiero Spalluto, Stefano Moro, Rosaria Volpini
"Dual Anta-Inhibitors" of the A 2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Beatrice Francucci, Simone Angeloni, Diego Dal Ben, Catia Lambertucci, Massimo Ricciutelli, Andrea Spinaci, Aleksei N Smirnov, Rosaria Volpini, Michela Buccioni, Gabriella Marucci
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A 2A Adenosine Receptor Useful in Neurodegenerative Disorders. Molecules (Basel, Switzerland) 28 (12) (2023)
Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions. Molecules (Basel, Switzerland) 28 (4) (2023)
Beatrice Francucci, Simone Angeloni, Diego Dal Ben, Catia Lambertucci, Massimo Ricciutelli, Andrea Spinaci, Aleksei N Smirnov, Rosaria Volpini, Michela Buccioni, Gabriella Marucci
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A 2A Adenosine Receptor Useful in Neurodegenerative Disorders. Molecules (Basel, Switzerland) 28 (12) (2023)
Francesco Pellicani, Diego Dal Ben, Andrea Perali, Sebastiano Pilati
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions. Molecules (Basel, Switzerland) 28 (4) (2023)
Andrea Spinaci, Catia Lambertucci, Michela Buccioni, Diego Dal Ben, Claudia Graiff, Maria Cristina Barbalace, Silvana Hrelia, Cristina Angeloni, Seyed Khosrow Tayebati, Massimo Ubaldi, Alessio Masi, Karl-Norbert Klotz, Rosaria Volpini, Gabriella Marucci
A 2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? Molecules (Basel, Switzerland) 27 (8) (2022)
Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Federica Maggi, Gabriella Marucci, Beatrice Francucci, Giorgio Santoni, Catia Lambertucci, Rosaria Volpini
A 3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Beatrice Francucci, Diego Dal Ben, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini, Gabriella Marucci, Michela Buccioni
A patent review of adenosine A 2B receptor antagonists (2016-present). Expert opinion on therapeutic patents 32 (6) (2022)
Daniela Catarzi, Flavia Varano, Erica Vigiani, Sara Calenda, Fabrizio Melani, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Natascia Mennini, Giulia Nerli, Diego Dal Ben, Rosaria Volpini, Vittoria Colotta
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Gabriella Marucci, Diego Dal Ben, Catia Lambertucci, Aleix Martí Navia, Andrea Spinaci, Rosaria Volpini, Michela Buccioni
Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation. Molecules (Basel, Switzerland) 26 (4) (2021)
Flavia Varano, Daniela Catarzi, Erica Vigiani, Diego Dal Ben, Michela Buccioni, Gabriella Marucci, Di Cesare Mannelli Lorenzo, Elena Lucarini, Carla Ghelardini, Rosaria Volpini, Vittoria Colotta
Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Diego Dal Ben, Luca Antonioli, Catia Lambertucci, Andrea Spinaci, Matteo Fornai, Vanessa D'Antongiovanni, Carolina Pellegrini, Corrado Blandizzi, Rosaria Volpini
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases. Expert opinion on drug discovery 15 (6) (2020)
Aleix Martí Navia, Diego Dal Ben, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini, Inês Marques-Morgado, Joana E Coelho, Luísa V Lopes, Gabriella Marucci, Michela Buccioni
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists. Cells 9 (7) (2020)
Luca Antonioli, Elena Lucarini, Catia Lambertucci, Matteo Fornai, Carolina Pellegrini, Laura Benvenuti, Di Cesare Mannelli Lorenzo, Andrea Spinaci, Gabriella Marucci, Corrado Blandizzi, Carla Ghelardini, Rosaria Volpini, Diego Dal Ben
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis. Cells 9 (6) (2020)
Marco Betti, Daniela Catarzi, Flavia Varano, Matteo Falsini, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Lorenzo di Cesare Mannelli, Carla Ghelardini, Elena Lucarini, Diego Dal Ben, Andrea Spinaci, Gianluca Bartolucci, Marta Menicatti, Vittoria Colotta
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity. Journal of medicinal chemistry 62 (15) (2019)
Gabriella Marucci, Diego Dal Ben, Michela Buccioni, Aleix Martí Navia, Andrea Spinaci, Rosaria Volpini, Catia Lambertucci
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications. Expert opinion on therapeutic patents 29 (12) (2019)
Daniela Catarzi, Flavia Varano, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Diego Dal Ben, Rosaria Volpini, Vittoria Colotta
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists. Pharmaceuticals (Basel, Switzerland) 12 (4) (2019)
Matteo Falsini, Daniela Catarzi, Flavia Varano, Costanza Ceni, Diego Dal Ben, Gabriella Marucci, Michela Buccioni, Rosaria Volpini, Lorenzo Di Cesare Mannelli, Elena Lucarini, Carla Ghelardini, Gianluca Bartolucci, Marta Menicatti, Vittoria Colotta
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain. Journal of medicinal chemistry 62 (18) (2019)
Pierre Matricon, Anirudh Ranganathan, Eugene Warnick, Zhan-Guo Gao, Axel Rudling, Catia Lambertucci, Gabriella Marucci, Aitakin Ezzati, Mariama Jaiteh, Diego Dal Ben, Kenneth A Jacobson, Jens Carlsson
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site. Scientific reports 7 (1) (2017)
Michela Buccioni, Diego Dal Ben, Catia Lambertucci, Filippo Maggi, Fabrizio Papa, Ajiroghene Thomas, Claudia Santinelli, Gabriella Marucci
Antiproliferative evaluation of isofuranodiene on breast and prostate cancer cell lines. TheScientificWorldJournal 2014 (2014)

Diego Dal Ben.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Diego Dal Ben